Aspirin greatly improves colorectal cancer five year survival rates for for patients whose tumors harbored a mutation in the gene PIK3CA
Aspirin therapy can extend the life of colorectal cancer patients whose tumors carry a mutation in a key gene, but it has no effect on patients who lack the mutation, Harvard-affiliated Dana-Farber Cancer Institute scientists report in the Oct. 25 issue of the New England Journal of Medicine. In a study involving more than 900… Read More »